Zohaib Salahuddin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zohaib Salahuddin has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Philippe Lambin
The D-Lab, Department of Precision Medicine, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands
9 shared publications - Henry C. Woodruff
Department of Precision Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands
7 shared publications - Abdalla Ibrahim
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
3 shared publications Henry C. Woodruff
Maastricht University
3 shared publicationsPhilippe Lambin
Maastricht University
3 shared publications- Ayoub Mokhtari
Radiology Department, Institut Jules Bordet, HUB-University Hospital of Brussels, 90 Rue Meylemeersch, 1070 Brussels, Belgium
2 shared publications
Latest Publications
- Open Access
Light-sheet fluorescence microscopy of optically cleared human head-and-neck organs: three-dimensional tissue assessment and histological correlation
Conventional histology provides detailed cellular information but only a partial view of the three-dimensional (3D) organisation of head-and-neck tissues. We investigated whether optical tissue clearing combined with light-sheet fluorescence microscopy (LSFM) could visualise the microanatomy of large head-and-neck specimens and relate volumetric features to conventional histology. Non-neoplastic human palatine tonsil, cervical lymph node, tongue and parotid gland specimens were cleared with a solvent-based protocol, labelled with small-molecule dyes and imaged by LSFM, with haematoxylin and eosin (H&E) histology as a morphological reference. LSFM visualised the characteristic architecture of each tissue, including lymphoid follicles and crypt epithelium in tonsil, cortex, paracortex and follicles in lymph node, epithelium and intrinsic muscle fibres in tongue, and lobules, ducts and adipocytes in parotid. Following structures through successive optical sections revealed their continuity and branching over long distances, information not available from single sections. Tongue epithelial measurements were comparable with H&E, and segmentation enabled volumetric quantification of structures such as the tongue epithelium and parotid adipocytes. Optical clearing and LSFM thus provide a feasible single workflow for volumetric investigation of human head-and-neck microanatomy. These data establish a 3D morphological reference with potential applications in cancer research and staging, computational image analysis and anatomical education, to be further developed through larger donor cohorts and specific labelling.
Open AccessLight-sheet fluorescence microscopy of optically cleared human head-and-neck organs: three-dimensional tissue assessment and histological correlation
Conventional histology provides detailed cellular information but only a partial view of the three-dimensional (3D) organisation of head-and-neck tissues. We investigated whether optical tissue clearing combined with light-sheet fluorescence microscopy (LSFM) could visualise the microanatomy of large head-and-neck specimens and relate volumetric features to conventional histology. Non-neoplastic human palatine tonsil, cervical lymph node, tongue and parotid gland specimens were cleared with a solvent-based protocol, labelled with small-molecule dyes and imaged by LSFM, with haematoxylin and eosin (H&E) histology as a morphological reference. LSFM visualised the characteristic architecture of each tissue, including lymphoid follicles and crypt epithelium in tonsil, cortex, paracortex and follicles in lymph node, epithelium and intrinsic muscle fibres in tongue, and lobules, ducts and adipocytes in parotid. Following structures through successive optical sections revealed their continuity and branching over long distances, information not available from single sections. Tongue epithelial measurements were comparable with H&E, and segmentation enabled volumetric quantification of structures such as the tongue epithelium and parotid adipocytes. Optical clearing and LSFM thus provide a feasible single workflow for volumetric investigation of human head-and-neck microanatomy. These data establish a 3D morphological reference with potential applications in cancer research and staging, computational image analysis and anatomical education, to be further developed through larger donor cohorts and specific labelling.
- 7 November 2025
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 23 (1) , 86
Reply to ‘Radiomics Quality Score 2.0: what changed from version 1.0 and why it matters’
- 7 November 2025
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 23 (1) , 86
Reply to ‘Radiomics Quality Score 2.0: what changed from version 1.0 and why it matters’
- Top Cited Papers
- 3 September 2025
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 22 (11) , 831-846
Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine
Radiomics is a tool for medical imaging analysis that could have a relevant role in precision oncology by offering precise quantitative support for clinical decision-making. The Radiomics Quality Score (RQS) is a tool developed to assess the rigour of radiomics studies that has now been widely adopted by researchers. Although RQS version 1.0 established a benchmark, an updated framework is required to account for evolving knowledge and ensure optimal evaluation of the quality of radiomics studies through the inclusion of fairness, explainability, rigorous quality control and harmonization. In this Review, we introduce the updated RQS 2.0, which maintains the scientific rigour of its predecessor and addresses these contemporary needs, and therefore could potentially accelerate clinical translation. Moreover, we introduce the radiomics readiness levels, inspired by the technology readiness level framework, which are integrated in RQS 2.0 and reflect nine distinct levels of incremental improvement in radiomics research with the ultimate aim of clinical implementation. We also detail anticipated future directions in radiomics, outlining a strategic vision to advance precision oncology, which is the ultimate aim of RQS 2.0.
- 3 September 2025
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 22 (11) , 831-846
Top Cited PapersRadiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine
Radiomics is a tool for medical imaging analysis that could have a relevant role in precision oncology by offering precise quantitative support for clinical decision-making. The Radiomics Quality Score (RQS) is a tool developed to assess the rigour of radiomics studies that has now been widely adopted by researchers. Although RQS version 1.0 established a benchmark, an updated framework is required to account for evolving knowledge and ensure optimal evaluation of the quality of radiomics studies through the inclusion of fairness, explainability, rigorous quality control and harmonization. In this Review, we introduce the updated RQS 2.0, which maintains the scientific rigour of its predecessor and addresses these contemporary needs, and therefore could potentially accelerate clinical translation. Moreover, we introduce the radiomics readiness levels, inspired by the technology readiness level framework, which are integrated in RQS 2.0 and reflect nine distinct levels of incremental improvement in radiomics research with the ultimate aim of clinical implementation. We also detail anticipated future directions in radiomics, outlining a strategic vision to advance precision oncology, which is the ultimate aim of RQS 2.0.
- 15 August 2024
- Published by Maastricht University
Towards trustworthy artificial intelligence in medical imaging
- 15 August 2024
- Published by Maastricht University
Towards trustworthy artificial intelligence in medical imaging
- Open Access
- 28 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 712
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
Purpose. This multicenter retrospective study aims to identify reliable clinical and radiomic features to build machine learning models that predict progression-free survival (PFS) and overall survival (OS) in pancreatic ductal adenocarcinoma (PDAC) patients. Methods. Between 2010 and 2020 pre-treatment contrast-enhanced CT scans of 287 pathology-confirmed PDAC patients from two sites of the Hopital Universitaire de Bruxelles (HUB) and from 47 hospitals within the HUB network were retrospectively analysed. Demographic, clinical, and survival data were also collected. Gross tumour volume (GTV) and non-tumoral pancreas (RPV) were semi-manually segmented and radiomics features were extracted. Patients from two HUB sites comprised the training dataset, while those from the remaining 47 hospitals of the HUB network constituted the testing dataset. A three-step method was used for feature selection. Based on the GradientBoostingSurvivalAnalysis classifier, different machine learning models were trained and tested to predict OS and PFS. Model performances were assessed using the C-index and Kaplan–Meier curves. SHAP analysis was applied to allow for post hoc interpretability. Results. A total of 107 radiomics features were extracted from each of the GTV and RPV. Fourteen subgroups of features were selected: clinical, GTV, RPV, clinical & GTV, clinical & GTV & RPV, GTV-volume and RPV-volume both for OS and PFS. Subsequently, 14 Gradient Boosting Survival Analysis models were trained and tested. In the testing dataset, the clinical & GTV model demonstrated the highest performance for OS (C-index: 0.72) among all other models, while for PFS, the clinical model exhibited a superior performance (C-index: 0.70). Conclusions. An integrated approach, combining clinical and radiomics features, excels in predicting OS, whereas clinical features demonstrate strong performance in PFS prediction.
- 28 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 712
Open AccessDevelopment of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
Purpose. This multicenter retrospective study aims to identify reliable clinical and radiomic features to build machine learning models that predict progression-free survival (PFS) and overall survival (OS) in pancreatic ductal adenocarcinoma (PDAC) patients. Methods. Between 2010 and 2020 pre-treatment contrast-enhanced CT scans of 287 pathology-confirmed PDAC patients from two sites of the Hopital Universitaire de Bruxelles (HUB) and from 47 hospitals within the HUB network were retrospectively analysed. Demographic, clinical, and survival data were also collected. Gross tumour volume (GTV) and non-tumoral pancreas (RPV) were semi-manually segmented and radiomics features were extracted. Patients from two HUB sites comprised the training dataset, while those from the remaining 47 hospitals of the HUB network constituted the testing dataset. A three-step method was used for feature selection. Based on the GradientBoostingSurvivalAnalysis classifier, different machine learning models were trained and tested to predict OS and PFS. Model performances were assessed using the C-index and Kaplan–Meier curves. SHAP analysis was applied to allow for post hoc interpretability. Results. A total of 107 radiomics features were extracted from each of the GTV and RPV. Fourteen subgroups of features were selected: clinical, GTV, RPV, clinical & GTV, clinical & GTV & RPV, GTV-volume and RPV-volume both for OS and PFS. Subsequently, 14 Gradient Boosting Survival Analysis models were trained and tested. In the testing dataset, the clinical & GTV model demonstrated the highest performance for OS (C-index: 0.72) among all other models, while for PFS, the clinical model exhibited a superior performance (C-index: 0.70). Conclusions. An integrated approach, combining clinical and radiomics features, excels in predicting OS, whereas clinical features demonstrate strong performance in PFS prediction.
- 7 March 2024
- Published by Springer Nature
- p. 40-46
Leveraging Uncertainty Estimation for Segmentation of Kidney, Kidney Tumor and Kidney Cysts
- 7 March 2024
- Published by Springer Nature
- p. 40-46
Leveraging Uncertainty Estimation for Segmentation of Kidney, Kidney Tumor and Kidney Cysts
- Open Access
An Interpretable Radiomics Model Based on Two-Dimensional Shear Wave Elastography for Predicting Symptomatic Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Objective: The aim of this study was to develop and validate an interpretable radiomics model based on two-dimensional shear wave elastography (2D-SWE) for symptomatic post-hepatectomy liver failure (PHLF) prediction in patients undergoing liver resection for hepatocellular carcinoma (HCC). Methods: A total of 345 consecutive patients were enrolled. A five-fold cross-validation was performed during training, and the models were evaluated in the independent test cohort. A multi-patch radiomics model was established based on the 2D-SWE images for predicting symptomatic PHLF. Clinical features were incorporated into the models to train the clinical–radiomics model. The radiomics model and the clinical–radiomics model were compared with the clinical model comprising clinical variables and other clinical predictive indices, including the model for end-stage liver disease (MELD) score and albumin–bilirubin (ALBI) score. Shapley Additive exPlanations (SHAP) was used for post hoc interpretability of the radiomics model. Results: The clinical–radiomics model achieved an AUC of 0.867 (95% CI 0.787–0.947) in the five-fold cross-validation, and this score was higher than that of the clinical model (AUC: 0.809; 95% CI: 0.715–0.902) and the radiomics model (AUC: 0.746; 95% CI: 0.681–0.811). The clinical–radiomics model showed an AUC of 0.822 in the test cohort, higher than that of the clinical model (AUC: 0.684, p = 0.007), radiomics model (AUC: 0.784, p = 0.415), MELD score (AUC: 0.529, p < 0.001), and ALBI score (AUC: 0.644, p = 0.016). The SHAP analysis showed that the first-order radiomics features, including first-order maximum 64 × 64, first-order 90th percentile 64 × 64, and first-order 10th percentile 32 × 32, were the most important features for PHLF prediction. Conclusion: An interpretable clinical–radiomics model based on 2D-SWE and clinical variables can help in predicting symptomatic PHLF in HCC.
Open AccessAn Interpretable Radiomics Model Based on Two-Dimensional Shear Wave Elastography for Predicting Symptomatic Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Objective: The aim of this study was to develop and validate an interpretable radiomics model based on two-dimensional shear wave elastography (2D-SWE) for symptomatic post-hepatectomy liver failure (PHLF) prediction in patients undergoing liver resection for hepatocellular carcinoma (HCC). Methods: A total of 345 consecutive patients were enrolled. A five-fold cross-validation was performed during training, and the models were evaluated in the independent test cohort. A multi-patch radiomics model was established based on the 2D-SWE images for predicting symptomatic PHLF. Clinical features were incorporated into the models to train the clinical–radiomics model. The radiomics model and the clinical–radiomics model were compared with the clinical model comprising clinical variables and other clinical predictive indices, including the model for end-stage liver disease (MELD) score and albumin–bilirubin (ALBI) score. Shapley Additive exPlanations (SHAP) was used for post hoc interpretability of the radiomics model. Results: The clinical–radiomics model achieved an AUC of 0.867 (95% CI 0.787–0.947) in the five-fold cross-validation, and this score was higher than that of the clinical model (AUC: 0.809; 95% CI: 0.715–0.902) and the radiomics model (AUC: 0.746; 95% CI: 0.681–0.811). The clinical–radiomics model showed an AUC of 0.822 in the test cohort, higher than that of the clinical model (AUC: 0.684, p = 0.007), radiomics model (AUC: 0.784, p = 0.415), MELD score (AUC: 0.529, p < 0.001), and ALBI score (AUC: 0.644, p = 0.016). The SHAP analysis showed that the first-order radiomics features, including first-order maximum 64 × 64, first-order 90th percentile 64 × 64, and first-order 10th percentile 32 × 32, were the most important features for PHLF prediction. Conclusion: An interpretable clinical–radiomics model based on 2D-SWE and clinical variables can help in predicting symptomatic PHLF in HCC.
- Open Access
- 13 April 2023
- Published by European Medical Group in EMJ Radiology
- Vol. 4 (1) , 43-45
Development and Validation of a Radiomics-Based Decision-Making Supporting Tool to Improve the Management and Outcome of Patients with Pancreatic Cancer
The aims of the study were to identify reliable clinical and radiomics features to build machine learning models predicting...
- 13 April 2023
- Published by European Medical Group in EMJ Radiology
- Vol. 4 (1) , 43-45
Open AccessDevelopment and Validation of a Radiomics-Based Decision-Making Supporting Tool to Improve the Management and Outcome of Patients with Pancreatic Cancer
The aims of the study were to identify reliable clinical and radiomics features to build machine learning models predicting...
- Open Access
From Head and Neck Tumour and Lymph Node Segmentation to Survival Prediction on PET/CT: An End-to-End Framework Featuring Uncertainty, Fairness, and Multi-Region Multi-Modal Radiomics
Automatic delineation and detection of the primary tumour (GTVp) and lymph nodes (GTVn) using PET and CT in head and neck cancer and recurrence-free survival prediction can be useful for diagnosis and patient risk stratification. We used data from nine different centres, with 524 and 359 cases used for training and testing, respectively. We utilised posterior sampling of the weight space in the proposed segmentation model to estimate the uncertainty for false positive reduction. We explored the prognostic potential of radiomics features extracted from the predicted GTVp and GTVn in PET and CT for recurrence-free survival prediction and used SHAP analysis for explainability. We evaluated the bias of models with respect to age, gender, chemotherapy, HPV status, and lesion size. We achieved an aggregate Dice score of 0.774 and 0.760 on the test set for GTVp and GTVn, respectively. We observed a per image false positive reduction of 19.5% and 7.14% using the uncertainty threshold for GTVp and GTVn, respectively. Radiomics features extracted from GTVn in PET and from both GTVp and GTVn in CT are the most prognostic, and our model achieves a C-index of 0.672 on the test set. Our framework incorporates uncertainty estimation, fairness, and explainability, demonstrating the potential for accurate detection and risk stratification.
Open AccessFrom Head and Neck Tumour and Lymph Node Segmentation to Survival Prediction on PET/CT: An End-to-End Framework Featuring Uncertainty, Fairness, and Multi-Region Multi-Modal Radiomics
Automatic delineation and detection of the primary tumour (GTVp) and lymph nodes (GTVn) using PET and CT in head and neck cancer and recurrence-free survival prediction can be useful for diagnosis and patient risk stratification. We used data from nine different centres, with 524 and 359 cases used for training and testing, respectively. We utilised posterior sampling of the weight space in the proposed segmentation model to estimate the uncertainty for false positive reduction. We explored the prognostic potential of radiomics features extracted from the predicted GTVp and GTVn in PET and CT for recurrence-free survival prediction and used SHAP analysis for explainability. We evaluated the bias of models with respect to age, gender, chemotherapy, HPV status, and lesion size. We achieved an aggregate Dice score of 0.774 and 0.760 on the test set for GTVp and GTVn, respectively. We observed a per image false positive reduction of 19.5% and 7.14% using the uncertainty threshold for GTVp and GTVn, respectively. Radiomics features extracted from GTVn in PET and from both GTVp and GTVn in CT are the most prognostic, and our model achieves a C-index of 0.672 on the test set. Our framework incorporates uncertainty estimation, fairness, and explainability, demonstrating the potential for accurate detection and risk stratification.
- 18 March 2023
- Published by Springer Nature
- p. 212-220
HNT-AI: An Automatic Segmentation Framework for Head and Neck Primary Tumors and Lymph Nodes in FDG- PET/CT Images
- 18 March 2023
- Published by Springer Nature
- p. 212-220
HNT-AI: An Automatic Segmentation Framework for Head and Neck Primary Tumors and Lymph Nodes in FDG- PET/CT Images